Last reviewed · How we verify
NCT05631639
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
NA trial testing PillSense System in Upper Gastrointestinal Bleeding in 30 participants. Completed in 30 August 2021.
30 June 2021
Quick facts
| Lead sponsor | EnteraSense Limited |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 30 |
| Start date | 7 May 2021 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 August 2021 |
| Sites | 3 locations across Czechia |
Drugs / interventions tested
- PillSense System
Conditions studied
- Upper Gastrointestinal Bleeding — all drugs for Upper Gastrointestinal Bleeding →
Sponsor
EnteraSense Limited
Who can join
Adults 18 to 80, any sex, with Upper Gastrointestinal Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multi-center, prospective, non-randomized, open-label, exploratory clinical investigation performed to evaluate safety and effectiveness of the PillSense System when used for detection of blood in the stomach of patients suspected to have an Upper Gastrointestinal Bleed (UGIB).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05631639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PillSense System
Trials testing the same drug.
- NCT05631652 — Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -Healthy Volunteers Study · NA · completed
Other recruiting trials for Upper Gastrointestinal Bleeding
Currently open trials in the same condition.
- NCT04902248 — OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding · NA · recruiting
Other EnteraSense Limited trials
Trials by the same sponsor.
- NCT05385224 — PillSense System for Detecting UGI Bleed · NA · completed
- NCT05631652 — Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -Healthy Volunteers Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05631639 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by EnteraSense Limited
- Last refreshed: 30 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05631639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing